Nippon Kayaku Plans Own Sales Staff,Trials in China

摘要

Nippon Kayaku has formed a project team to prepare for its full-fledged advancement into the Chinese market in light of the market's enormous potential.The company has been selling bleomycin for the treatment of such cancers as skin cancer,head and neck cancer,and lymphoma to Chinese dealers through its office in Beijing,but has as yet no medical representatives of its own in the country.